Evaluation of glucocorticoid in treatment for patients with acute respiratory distress syndrome

OBJECTIVE: To value of glucocorticoid (GC) in treatment for patients with acute respiratory distress syndrome (ARDS) was evaluated

Bibliographische Detailangaben
Veröffentlicht in:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 15(2003), 6 vom: 01. Juni, Seite 349-53
1. Verfasser: Song, Zhi-fang (VerfasserIn)
Weitere Verfasser: Guo, Xiao-hong, Wang, Shu-yun, Xie, Wei, Yin, Na, Zhang, Yue, Shan, Hui-min, Li, Wen-hua
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2003
Zugriff auf das übergeordnete Werk:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Schlagworte:Comparative Study English Abstract Journal Article Research Support, Non-U.S. Gov't Glucocorticoids
LEADER 01000caa a22002652 4500
001 NLM125993501
003 DE-627
005 20250204033311.0
007 tu
008 231222s2003 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0420.xml 
035 |a (DE-627)NLM125993501 
035 |a (NLM)12837167 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Song, Zhi-fang  |e verfasserin  |4 aut 
245 1 0 |a Evaluation of glucocorticoid in treatment for patients with acute respiratory distress syndrome 
264 1 |c 2003 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 18.07.2003 
500 |a Date Revised 15.11.2006 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To value of glucocorticoid (GC) in treatment for patients with acute respiratory distress syndrome (ARDS) was evaluated 
520 |a METHODS: The clinical data from all patients with ARDS in medical ICU (MICU) during May 2000 to Aug. 2002 were collected. They were divided into two groups, GC and non-GC groups, in order to compare their age, sex, acute physiology and chronic health evaluation II (APACHE II) score, PaO2/FiO2, Qs/Qt, level of positive end-expiratory pressure(PEEP), mortality and dead reason of death, depending on whether GC was given or not. In cases with administration of GC, the dosage, as well as duration of treatment was analyzed in terms of the overcome 
520 |a RESULTS: There were 77 cases totally, among them 60 cases were of GC group and 17 of non -GC. Their age, sex, APACHE II score, PaO2/FiO2, Qs/Qt, use of artificial ventilation and its duration, level of PEEP, and the extent of relief from hypoxemia showed no significant differences between two groups (P>0.05). Even the mortality for patients who were treated with GC was higher than those without (71.7% vs. 52.9%), though there was no statistically significant difference (P>0.05). The percentage of patients died primarily of ARDS was low in both groups (7.0% and 11.1%). The age, APACHE II score and underlying diseases for non-survivors were older and higher than survivors (P<0.001 or P<0.005) and their duration of staying in ICU was shorter than the latter (P<0.05). The mortality of patients who were given GC before or during 24 hours of the establishment of the diagnosis of ARDS (66.7% and 68.2%) was lower than those who were given GC 24 hours after the diagnosis of ARDS (90.0%) 
520 |a CONCLUSION: GC could be one of effective treatments for ARDS, and it should be given without hesitation when refractory hypoxemia and shock were found 
650 4 |a Comparative Study 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Glucocorticoids  |2 NLM 
700 1 |a Guo, Xiao-hong  |e verfasserin  |4 aut 
700 1 |a Wang, Shu-yun  |e verfasserin  |4 aut 
700 1 |a Xie, Wei  |e verfasserin  |4 aut 
700 1 |a Yin, Na  |e verfasserin  |4 aut 
700 1 |a Zhang, Yue  |e verfasserin  |4 aut 
700 1 |a Shan, Hui-min  |e verfasserin  |4 aut 
700 1 |a Li, Wen-hua  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue  |d 1998  |g 15(2003), 6 vom: 01. Juni, Seite 349-53  |w (DE-627)NLM098227793  |x 1003-0603  |7 nnns 
773 1 8 |g volume:15  |g year:2003  |g number:6  |g day:01  |g month:06  |g pages:349-53 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 15  |j 2003  |e 6  |b 01  |c 06  |h 349-53